FdaApplication
ANDA 207628
Identifiers
- fda_app_no: ANDA207628
Properties
| Property | Value |
|---|---|
| applicant_name | LUOXIN AUROVITAS PHARMA CHENGDU CO LTD |
| application_type | ANDA |
| approval_date | 2017-01-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.25% BASE | SOLUTION;INHALATION |
1 product